Shares of HIMS experienced a dramatic slump today following the unexpected cancellation of its deal with pharmaceutical giant Novo Nordisk. Investors interpreted negatively to the news, sending the company's stock price plummeting by over fifteen percent. The reason for the breakdown of the partnership remains unclear, but industry analysts specula